Taking decisions on expenditure for high‐cost drugs at the regional level: a model for evaluating the overall impact of Trastuzumab in the Veneto Region of Italy

, , , , , , , , &
Journal of Evaluation in Clinical Practice 17 (2):298-303 (2011)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1111/j.1365-2753.2010.01440.x

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Making Fair Funding Decisions for High Cost Cancer Care: The Case of Herceptin in New Zealand.E. Fenton - 2010 - Public Health Ethics 3 (2):137-146.
Futility, Autonomy, and Cost in End-of-Life Care.Mary Ann Baily - 2011 - Journal of Law, Medicine and Ethics 39 (2):172-182.
Decision analysis model evaluating the cost‐effectiveness of risperidone, olanzapine and haloperidol in the treatment of schizophrenia.Mark Bounthavong & Mark P. Okamoto - 2007 - Journal of Evaluation in Clinical Practice 13 (3):453-460.
On the Observability of Purely Behavioral Sunk-Cost Effects: Theoretical and Empirical Support for the BISC Model.Marcus Cunha & Fabio Caldieraro - 2010 - Cognitive Science 34 (8):1384-1387.
An Integrated Approach to Resource Allocation.Louise M. Terry - 2004 - Health Care Analysis 12 (2):171-180.
The opportunity cost model: Automaticity, individual differences, and self-control resources.Martin S. Hagger - 2013 - Behavioral and Brain Sciences 36 (6):687-688.
Decision modelling of economic evaluation of intervention programme of breast cancer.Jung-Chen Chang, Tony H.-H. Chen, Stephen W. Duffy, Amy M.-F. Yen & Sam L.-S. Chen - 2010 - Journal of Evaluation in Clinical Practice 16 (6):1282-1288.
Cost‐utility analysis of bevacizumab versus ranibizumab in neovascular age‐related macular degeneration using a Markov model.Jignesh J. Patel, Margaret As Mendes, Mark Bounthavong, Melissa Ld Christopher, Daniel Boggie & Anthony P. Morreale - 2012 - Journal of Evaluation in Clinical Practice 18 (2):247-255.
Beyond simple utility in predicting self-control fatigue: A proximate alternative to the opportunity cost model.Michael Inzlicht & Brandon J. Schmeichel - 2013 - Behavioral and Brain Sciences 36 (6):695-696.
Impact of advanced exercise ECG analysis on cost of coronary artery disease management.Riccardo Bigi, Alberto Ferrando, Eva Pagano, Lauro Cortigiani, Franco Merletti, Cesare Fiorentini & Dario Gregori - 2010 - Journal of Evaluation in Clinical Practice 16 (4):678-684.
Decisions on Inclusion in the Swedish Basic Health Care Package—Roles of Cost-Effectiveness and Need.Lars Bernfort - 2003 - Health Care Analysis 11 (4):301-308.
Cost analysis of the utilization of new vascular grafts.Raphael Adar & Nava Pliskin - 1980 - Theoretical Medicine and Bioethics 1 (2):213-223.
The moral relevance of cost.Bashshar Haydar - 2003 - Philosophical Studies 112 (2):127 - 134.
Does Cost Effectiveness Analysis Unfairly Discriminate against People with Disabilities?Greg Bognar - 2010 - Journal of Applied Philosophy 27 (4):394-408.

Analytics

Added to PP
2013-11-24

Downloads
34 (#458,553)

6 months
7 (#411,886)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references